Current status and future perspective of radiopharmaceuticals in China
Authors:
- 12 November 2021
- journal article
- review article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 49 (8) , 2514-2530
Abstract
Radiopharmaceuticals are essential components of nuclear medicine and serve as one of the cornerstones of molecular imaging and precision medicine. They provide new means and approaches for early diagnosis and treatment of diseases. After decades of development and hard efforts, a relatively matured radiopharmaceutical production and management system has been established in China with high-quality facilities. This review provides an overview of the current status of radiopharmaceuticals on production and distribution, clinical application, and regulatory supervision and also describes some important advances in research and development and clinical translation of radiopharmaceuticals in the past 10 years. Moreover, some prospects of research and development of radiopharmaceuticals in the near future are discussed.Keywords
This publication has 73 references indexed in Scilit:
- Small-Animal SPECT/CT of the Progression and Recovery of Rat Liver Fibrosis by Using an Integrin αvβ3–targeting RadiotracerRadiology, 2016
- 18F-Labeled 1,4-Dioxa-8-azaspiro[4.5]decane Derivative: Synthesis and Biological Evaluation of a σ1Receptor Radioligand with Low Lipophilicity as Potent Tumor Imaging AgentJournal of Medicinal Chemistry, 2015
- Preliminary evaluation of [18F]AlF-NOTA-MAL-Cys39-exendin-4 in insulinoma with PETJournal of Drug Targeting, 2015
- Pilot Prospective Evaluation of 18F-Alfatide II for Detection of Skeletal MetastasesTheranostics, 2015
- 177Lu-Labeled Antibodies for EGFR-Targeted SPECT/CT Imaging and Radioimmunotherapy in a Preclinical Head and Neck Carcinoma ModelMolecular Pharmaceutics, 2014
- Radiopharmaceuticals in China: current status and prospectsRadiochimica Acta, 2014
- The development of radiotracers for imaging sigma (σ) receptors in the central nervous system (CNS) using positron emission tomography (PET)Journal of Labelled Compounds and Radiopharmaceuticals, 2013
- Efficacy and Safety of 177Lu-EDTMP in Bone Metastatic Pain Palliation in Breast Cancer and Hormone Refractory Prostate CancerClinical Nuclear Medicine, 2013
- Synthesis and Evaluation of Novel 18F Labeled 2-Pyridinylbenzoxazole and 2-Pyridinylbenzothiazole Derivatives as Ligands for Positron Emission Tomography (PET) Imaging of β-Amyloid PlaquesJournal of Medicinal Chemistry, 2012
- Astatine-211 labeling of insulin: Synthesis and preliminary evaluation in vivo and in vitroJournal of Radioanalytical and Nuclear Chemistry, 2007